Gilead Sciences, Inc. (GILD)
Last Price: 
Revenue: The sum of all revenue fields included for a company's operating activities.
Gilead Sciences, Inc. (GILD) had Revenue of $7.42B for the most recently reported fiscal quarter, ending 2020-12-31.
| Income Statement Financials | |
|
Revenue |
$7.42B |
$1.55B |
|
$1.40B |
|
$6.02B |
|
$4.77B |
|
$2.65B |
|
$-837.00M |
|
$1.81B |
|
$1.81B |
|
$1.54B |
|
$1.54B |
|
$1.54B |
|
$1.54B |
|
$2.65B |
|
$3.08B |
|
1.26B |
|
1.26B |
|
$1.24 |
|
$1.25 |
|
| Balance Sheet Financials | |
$16.00B |
|
$4.97B |
|
$52.41B |
|
$68.41B |
|
$11.40B |
|
$33.77B |
|
$38.79B |
|
$50.19B |
|
$18.22B |
|
$-23.01B |
|
$18.22B |
|
1.25B |
|
| Cash Flow Statement Financials | |
$8.17B |
|
$-14.62B |
|
$770.00M |
|
$11.63B |
|
$6.00B |
|
$-5.63B |
|
$643.00M |
|
$-3.45B |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.40 |
|
-- |
|
-- |
|
0.65 |
|
2.00 |
|
81.16% |
|
35.72% |
|
35.72% |
|
-- |
|
24.44% |
|
20.90% |
|
$7.52B |
|
-- |
|
-- |
|
-- |
|
0.11 |
|
0.83 |
|
1.52 |
|
59.33 |
|
8.47% |
|
-6.71% |
|
2.26% |
|
2.97% |
|
$14.53 |
|
$5.95 |
|
$6.47 |
|